Leading drug makers to face cancellation of product registrations.

Due to the credibility problems of the bio equivalency test data quite a number of local top drug makers may encounter with the registration cancellation of their products.

The KFDA has found that more than half of the bio equivalency test problems were the cases reported by Labfrontier, a leading bio equivalency test institute, as the total 38 products, the test data of which were not confo...